Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility - 08/11/12
, Biswajit Kar, M.D. b, c, d, Danny Chu, M.D. a, b, c, Lorraine D. Cornwell, M.D. a, b, Alvin Blaustein, M.D. b, d, Glenn N. Levine, M.D. b, d, David Paniagua, M.D. b, c, d, Hani Jneid, M.D. b, d, Corey Jensen, M.D. b, Prasad V. Atluri, M.D. b, Carlos F. Bechara, M.D. b, e, Panos Kougias, M.D. b, e, Chris Pawlak, M.H.A. b, Biykem Bozkurt, M.D. b, d, Thomas A. Burdon, M.D. f, Blase A. Carabello, M.D. b, c, d
Corresponding author. Tel.: +1-832-489-3202; fax: +1-713-794-7352Abstract |
Background |
The US Food and Drug Administration recently approved a transcatheter aortic valve for patients for whom open heart surgery is prohibitively risky.
Methods |
A multidisciplinary heart valve team partnered with administration to launch a transcatheter aortic valve replacement (TAVR) program. Clinical registries were used to show robust valve caseloads and outcomes at our Veterans Affairs (VA) facility and to project future volumes. A TAVR business plan was approved by the VA leadership as part of a multiphase project to upgrade and expand our surgical facilities.
Results |
The heart valve team completed a training program that included simulations and visits to established TAVR centers. Patients were evaluated and screened through a streamlined process, and the program was initiated successfully.
Conclusions |
Establishing a TAVR program at a VA facility requires a multidisciplinary team with experience in heart valve and endovascular therapies and a supportive administration willing to invest in a sophisticated infrastructure.
Le texte complet de cet article est disponible en PDF.Keywords : Aortic stenosis, Cardiac surgery, Transcatheter aortic valve replacement, Valve replacement
Plan
Vol 204 - N° 5
P. 643-648 - novembre 2012 Retour au numéro
Article précédent
- Poor survival for veterans with pathologic stage I non–small-cell lung cancer
- Jamii B. St. Julien, Rhonda Pinkerman, Melinda C. Aldrich, Heidi Chen, Stephen A. Deppen, Carol Callaway-Lane, Pierre Massion, Joe B. Putnam, Eric S. Lambright, Jonathan C. Nesbitt, Eric L. Grogan
- Percutaneous profunda femoris artery revascularization to prevent hip disarticulation: case series and review of the literature
- Mun Jye Poi, George Pisimisis, Neal R. Barshes, Peter H. Lin, Panos Kougias, Carlos F. Bechara
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?